sc 51089 has been researched along with ah 6809 in 4 studies
Studies (sc 51089) | Trials (sc 51089) | Recent Studies (post-2010) (sc 51089) | Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) |
---|---|---|---|---|---|
41 | 1 | 19 | 163 | 1 | 49 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heinemann, A; Holzer, P; Peskar, BA; Shahbazian, A | 1 |
Hamasaki, Y; Ishii, K; Matsuo, M; Yoshida, N; Zaitsu, M | 1 |
Matlhagela, K; Taub, M | 1 |
Amadio, P; Amato, M; Baldassarre, D; Barbieri, SS; Gianellini, S; Squellerio, I; Tarantino, E; Tremoli, E; Weksler, BB; Zacchi, E | 1 |
1 trial(s) available for sc 51089 and ah 6809
Article | Year |
---|---|
Production of prostaglandin E2 induced by cigarette smoke modulates tissue factor expression and activity in endothelial cells.
Topics: Adult; Aged; Aged, 80 and over; Animals; Dinoprostone; Endothelial Cells; Female; Gene Expression Regulation; Humans; Hydrazines; Interleukin-1beta; Male; Mice; Middle Aged; Myocardium; Oxazepines; Sirtuin 1; Smoking; Thromboplastin; Thrombosis; Xanthones | 2015 |
3 other study(ies) available for sc 51089 and ah 6809
Article | Year |
---|---|
Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dinoprostone; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Guinea Pigs; Hydantoins; Hydrazines; Iloprost; In Vitro Techniques; Intestine, Small; Leukotriene Antagonists; Leukotriene D4; Male; Oxazepines; Peristalsis; Prostaglandin D2; Prostaglandins A; Receptors, Leukotriene; Receptors, Prostaglandin; Xanthenes; Xanthones; Yohimbine | 2002 |
Inhibition of human glioma cell growth by a PHS-2 inhibitor, NS398, and a prostaglandin E receptor subtype EP1-selective antagonist, SC51089.
Topics: Animals; Brain Neoplasms; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Female; Glioma; Humans; Hydrazines; Isoenzymes; Membrane Proteins; Mice; Mice, SCID; Nitrobenzenes; Oxazepines; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Sulfonamides; Transplantation, Heterologous; Tumor Cells, Cultured; Xanthones | 2004 |
Involvement of EP1 and EP2 receptors in the regulation of the Na,K-ATPase by prostaglandins in MDCK cells.
Topics: Alprostadil; Animals; Cell Line; Dinoprostone; Dogs; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hydrazines; Ion Transport; Kidney Tubules, Distal; Oxazepines; Prostaglandin Antagonists; Protein Kinase C; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Sodium-Potassium-Exchanging ATPase; Xanthones | 2006 |